A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

Eefting, Daniel

A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. [electronic resource] - Cardiovascular research Nov 2010 - 367-75 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1755-3245

10.1093/cvr/cvq203 doi


Animals
Apolipoprotein E3--genetics
Aprotinin--biosynthesis
Atherosclerosis--genetics
Carotid Arteries--surgery
Cattle
Cell Line
Cell Proliferation
Disease Models, Animal
Electroporation
Fibrinolysin--antagonists & inhibitors
Genetic Therapy--methods
Graft Occlusion, Vascular--genetics
Humans
Hypercholesterolemia--genetics
Hyperplasia
Male
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases--metabolism
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Receptors, Urokinase Plasminogen Activator--metabolism
Recombinant Fusion Proteins--biosynthesis
Saphenous Vein--metabolism
Time Factors
Tissue Culture Techniques
Tissue Inhibitor of Metalloproteinase-1--biosynthesis
Transfection
Urokinase-Type Plasminogen Activator--biosynthesis
Venae Cavae--metabolism